CTRI/2024/06/068682Not yet recruitingPhase 2
Pilot Study to assess the efficacy of cannabinoid-rich Oral cannabis extract for pain management in cancer patients undergoing cancer directed treatment (surgery, systemic therapy, radiation therapy)and who have received systemic analgesics - NI
Whole leaf Organics Pvt Ltd0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Adult patients
- •Histopathologically confirmed cancer diagnosis
- •Moderate or severe pain
- •Stable regime of pain management inclusive of NSAIDS weak opioid opioids
- •Palliative intent therapy
Exclusion Criteria
- •Major psychiatric disorder
- •Cardiovascular disorder
- •Significant renal or hepatic impairment
- •Lactating Women
- •Patients who were currently using or had used cannabinoid based medications within 30
- •days of study entry
Investigators
Similar Trials
Completed
Phase 2
Siddha treatment for Joint paiCTRI/2010/091/006125ational Institute of Siddha Chennai Tamil Nadu India40
Recruiting
Phase 2
A pilot study to evaluate the therapeutic efficacy of kurosani ommumsathu (internal) in the management ofthookaminmai (insomnia)CTRI/2014/04/004520ATIONAL INSTITUTE OF SIDDHA10
Completed
Not Applicable
A pilot clinical trial to evaluate the efficacy and safety of R:GEN(Selective retina therapy) which induce to reduce drusen in patients with intermediate dry Age-related Macular DegeneratioDiseases of the eye and adnexaKCT0003227The Catholic University of Korea, Yeouido St. Mary's Hospital20
Completed
Phase 4
Exenatide -LAR in addition to standard care in Indigenous Australians with type 2 diabetes and effect on glycaemic controlMetabolic and Endocrine - DiabetesType 2 DiabetesACTRN12615000913572BakerIDI Heart and Diabetes Institute40
Recruiting
Phase 2
Evaluation of the effectiveness of Cyclotide complex herbal syrup in preventing COVID-19 virus in exposed individualsCOVID-19 viral disease.Coronavirus infection, unspecifiedB34.2IRCT20160131026298N4Bagheiat-allah University of Medical Sciences60